EDGAR Filing Documents for 0001654954-17-010615

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001654954-17-010615

Filing Date

2017-11-14

Accepted

2017-11-14 16:03:48

Documents

Period of Report

2017-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	gtbp_10q.htm	10-Q	559682
2	AGREEMENT AND PLAN OF MERGER	gtbp_ex2-1.htm	EX-2.1	294580
3	CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES J CO	gtbp_ex4-1.htm	EX-4.1	36317
4	EMPLOYMENT AGREEMENT WITH ANTHONY CATALDO	gtbp_ex10-1.htm	EX-10.1	93234
5	EMPLOYMENT AGREEMENT WITH DR. KATHLEEN CLARENCE SMITH	gtbp_ex10-2.htm	EX-10.2	89439
6	EMPLOYMENT AGREEMENT WITH STEVEN WELDON	gtbp_ex10-3.htm	EX-10.3	86574
7	EMPLOYMENT AGREEMENT WITH DR. RAYMOND URBANSKI	gtbp_ex10-4.htm	EX-10.4	88078
8	NOTE CONVERSION AGREEMENT	gtbp_ex10-5.htm	EX-10.5	234432
9	WARRANT CONVERSION AGREEMENT	gtbp_ex10-6.htm	EX-10.6	242789
10	PREFERRED CONVERSION AGREEMENT	gtbp_ex10-7.htm	EX-10.7	206532
11	AMENDED NOTE CONVERSION AGREEMENT	gtbp_ex10-8.htm	EX-10.8	24521
12	AMENDED WARRANT CONVERSION AGREEMENT	gtbp_ex10-9.htm	EX-10.9	24299
13	AMENDED PREFERRED CONVERSION AGREEMENT	gtbp_ex10-10.htm	EX-10.10	24310
14	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	gtbp_ex311.htm	EX-31.1	13564
15	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	gtbp_ex312.htm	EX-31.2	14145
16	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	gtbp_ex321.htm	EX-32.1	8466
17	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	gtbp_ex322.htm	EX-32.2	8767
	Complete submission text file	0001654954-17-010615.txt		3352981

Data Files

Seq	Description	Document	Type	Size
18	XBRL INSTANCE DOCUMENT	oxis-20170930.xml	EX-101.INS	224010
19	XBRL TAXONOMY EXTENSION SCHEMA	oxis-20170930.xsd	EX-101.SCH	22484
20	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	oxis-20170930_cal.xml	EX-101.CAL	33889
21	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	oxis-20170930_def.xml	EX-101.DEF	38127
22	XBRL TAXONOMY EXTENSION LABEL LINKBASE	oxis-20170930_lab.xml	EX-101.LAB	155784
23	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	oxis-20170930_pre.xml	EX-101.PRE	117213

Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602

Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888

GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)